GSK plc
Portfolio value QoQ: +0.5% 13F does not disclose cash
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.0% Est. buys $0 · sells $0
Performance vs S&P 500
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Sector breakdown
Full portfolio 13 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| CRSP | $175,652,997 | 29.17% | 3,220,627 | $22,447,771 | |||
| WVE | $106,007,465 | 17.60% | 18,245,691 | $-26,273,795 | |||
| VIR | $87,134,221 | 14.47% | 8,550,954 | $10,517,673 | |||
| BNTX | $82,798,123 | 13.75% | 889,824 | $3,710,566 | |||
| IDYA | $49,693,321 | 8.25% | 1,333,333 | $5,266,665 | |||
| CYTK | $29,001,573 | 4.82% | 340,434 | $6,563,568 | |||
| LYEL | $21,252,859 | 3.53% | 1,512,659 | $-9,091,081 | |||
| SPRO | $20,311,239 | 3.37% | 9,190,606 | $-1,194,779 | |||
| NKTX | $8,916,572 | 1.48% | 3,150,732 | $2,268,527 | |||
| FULC | $6,535,713 | 1.09% | 1,785,714 | $-7,160,713 | |||
| BCYC | $6,485,339 | 1.08% | 1,529,561 | $-611,824 | |||
| CVRX | $5,178,977 | 0.86% | 1,007,583 | $-4,352,758 | |||
| RGNX | $3,252,043 | 0.54% | 271,456 | $977,242 | |||
| No matches | |||||||
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| WVE | Price move only | +0 | -$26.3M |
| CRSP | Price move only | +0 | +$22.4M |
| VIR | Price move only | +0 | +$10.5M |
| LYEL | Price move only | +0 | -$9.1M |
| FULC | Price move only | +0 | -$7.2M |
| CYTK | Price move only | +0 | +$6.6M |
| IDYA | Price move only | +0 | +$5.3M |
| CVRX | Price move only | +0 | -$4.4M |
| BNTX | Price move only | +0 | +$3.7M |
| NKTX | Price move only | +0 | +$2.3M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.